Title Fight: Change Process to Tenecteplase | Visual Loss Due to Strokes and Stroke Mimics
Target Audience
Primary care physicians, family physicians, general internists, emergency medicine physicians, cardiologists, hospitalists, nurses, advanced practice providers, pharmacists, pharmacy technicians, occupational therapists, advanced practice registered nurses and emergency medical technicians.
Samaritan Physicians: Successful completion of this activity will qualify Samaritan physicians for annual policy discounts. Upon completion, please print your certificate and submit to Samaritan for consideration.
Learning Objectives
- Recognize contraindications to administration of tenecteplase IV for acute ischemic stroke (AIS).
- Determine the appropriate dosing, preparation and administration of tenecteplase IV for AIS.
- Identify required monitoring parameters during and after tenecteplase IV administration.
- Localize lesions causing visual loss within the nervous system.
- Describe the diagnostic evaluation of patients with visual loss.
- Describe potential treatment modalities for patients presenting with visual loss.
Kendra Kent, M.S., R.N., CCRN, CNRN, SCRN, CENP
Director, Neuroscience Programs
Marcus Neuroscience Institute
Boca Raton Regional Hospital
Baptist Health South Florida
Boca Raton, Florida
Diana Barratt, M.D., MPH, FAAN
Chair, FAU Neurology Residents
Marcus Neuroscience Institute
Boca Raton Regional Hospital
Baptist Health South Florida
Boca Raton, Florida
Kendra Kent, M.S., R.N., conference director and faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Diana Barratt, M.D., faculty for this educational activity, is an employee of Evolution Research Group, Clinical Trials and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
All of the relevant financial relationships listed for this individual have been mitigated.
Khalid Hanafy, M.D., Ph.D., and Kendra Kent, M.S., R.N., conference directors for this educational activity, have no relevant financial relationships with ineligible companies* to disclose.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Occupational Therapy
- 1.00 Florida Board of Pharmacy
Required Hardware/Software
![]() | PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| ||||||
![]() | Mobile UsersThis site is supported on the following mobile devices:
| ||||||
![]() | Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to [email protected] and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |